bucladesine and Angiogenesis, Pathologic

bucladesine has been researched along with Angiogenesis, Pathologic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andrade, MF; Ball, M; McDermid, A; Moreno, MJ; Stanimirovic, DB	1

Other Studies

1 other study(ies) available for bucladesine and Angiogenesis, Pathologic

Article	Year
Insulin-like growth factor binding protein-4 (IGFBP-4) is a novel anti-angiogenic and anti-tumorigenic mediator secreted by dibutyryl cyclic AMP (dB-cAMP)-differentiated glioblastoma cells. Glia, 2006, Volume: 53, Issue:8 Topics: Antineoplastic Agents; Blood Vessels; Brain Neoplasms; Bucladesine; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Cyclic AMP; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Insulin-Like Growth Factor Binding Protein 4; Neoplasm Invasiveness; Neovascularization, Pathologic; Vascular Endothelial Growth Factor A	2006

Article

Year

Insulin-like growth factor binding protein-4 (IGFBP-4) is a novel anti-angiogenic and anti-tumorigenic mediator secreted by dibutyryl cyclic AMP (dB-cAMP)-differentiated glioblastoma cells.

Glia, 2006, Volume: 53, Issue:8

Topics: Antineoplastic Agents; Blood Vessels; Brain Neoplasms; Bucladesine; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Cyclic AMP; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Insulin-Like Growth Factor Binding Protein 4; Neoplasm Invasiveness; Neovascularization, Pathologic; Vascular Endothelial Growth Factor A

2006